16 results
DEF 14A
BOLT
Bolt Biotherapeutics Inc
28 Apr 22
Definitive proxy
4:06pm
basic financial statements, being over 21 years of age and having the highest personal integrity and ethics. The nominating and corporate governance … . Healy, Richard A. Miller, and Nicole Onetto. The chairperson of our research and development committee is Dr. Onetto.
Code of Business Conduct and Ethics
10-K
f88h4 lg86
31 Mar 21
Annual report
4:06pm
424B4
5pjstt1k
5 Feb 21
Prospectus supplement with pricing info
4:44pm
S-1/A
veej6eaoxji0zknije
1 Feb 21
IPO registration (amended)
6:24am
S-1
EX-10.14
w67 38tmqy
15 Jan 21
IPO registration
3:58pm
S-1
ne7v22b5a7 9ah9q0i
15 Jan 21
IPO registration
3:58pm
DRS/A
sfpxw36gvjj
11 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
dssijxey9ykloy
11 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
uci2yc80
11 Sep 20
Draft registration statement (amended)
12:00am
DRS
jrq8gvjjr
10 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next